Defense Advanced Research Projects AgencyTagged Content List

Threat Countermeasures

Actions that mitigate adversaries' capabilities

Showing 22 results for Countermeasures + Therapy RSS
04/06/2020
Warfighters are travelers and thus suffer from travelers’ ailments including disrupted sleep cycles and limited access to safe food and water. Warfighters who have not slept well have lower alertness, weaker athletic performance, and greater disorientation. Current approaches to restoring wakefulness often lean on chemical methods that disrupt downstream sleep patterns and lead to exhaustion.
06/12/2020
Antibiotic resistance is on the rise and is recognized by both the CDC1 and the U.S. Military2 as a current – and formidable – global health threat. The U.S Department of Defense (DoD) has long documented the warfighter’s outsized risk of exposure to infectious disease, including the increasing number of multi-drug resistant (MDR) organisms that have challenged military wound care in Iraq and Afghanistan3. Despite this looming crisis, there has been a notable exodus of pharmaceutical companies from the antibiotic space, as well as several high-profile failures of biotechnology companies focused on antibiotic development4.
April 15, 2020,
Webinar
The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is hosting a Proposers Day for the potential proposer community in support of the Broad Agency Announcement (BAA) for the ADAPTER Program. The Proposers Day will be held on April 15, 2020 from 11:00 AM to 1:30 PM ET via Webinar.
February 22, 2017,
Crown Plaza Tysons Corner-McLean
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new Pandemic Prevention Platform (P3) program. P3 aims to develop an integrated, end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in 60 days or less. Performers will use nucleic-acid-based technologies pioneered by DARPA as a foundation for work to overcome the remaining bottlenecks preventing rapid response to pandemic threats.
March 2, 2017,
Doubletree by Hilton San Diego Downtown
DARPA’s Biological Technologies Office is hosting a Proposers Day meeting to provide information to potential applicants on the structure and objectives of the new Pandemic Prevention Platform (P3) program. P3 aims to develop an integrated, end-to-end platform that uses nucleic acid sequences to halt the spread of viral infections in 60 days or less. Performers will use nucleic-acid-based technologies pioneered by DARPA as a foundation for work to overcome the remaining bottlenecks preventing rapid response to pandemic threats.